PTPN11 and melanoma: In particular, the binding of the SH2 domain of SHP2 with specific regions of Gab2 is at the basis of several molecular pathways,20 and mutations occurring on both proteins are reported as causative of a number of different tumor diseases, such as breast, lung and gastric cancer, leukemia and melanoma.20, 21, 22, 23